Metal-containing nanomaterials have the potential to be used in dentistry for infection control, but little is known about their antibacterial properties. This study investigated the toxicity of silver (Ag), titanium dioxide and silica nanoparticles (NPs) against the oral pathogenic species of Streptococcus mutans, compared to the routine disinfectant, chlorhexidine. The bacteria were assessed using the minimum inhibitory concentration assay for growth, fluorescent staining for live/dead cells, and measurements of lactate. All the assays showed that Ag NPs had the strongest antibacterial activity of the NPs tested, with bacterial growth also being 25-fold lower than that in chlorhexidine. The survival rate of bacteria under the effect of 100 mg l−1 Ag NPs in the media was 2% compared to 60% with chlorhexidine, while the lactate concentration was 0.6 and 4.0 mM, respectively. Silica and titanium dioxide NPs had limited effects. Dialysis experiments showed negligible silver dissolution. Overall, Ag NPs were the best disinfectant and performed better than chlorhexidine. Improvements to the MIC assay are suggested.
Nanomaterials are now being manufactured and used in many products. However, our knowledge of the human health effects and environmental concentrations of engineered nanomaterials or nanoparticles is incomplete. This article gives a toxicologists perspective, outlining possible routes of uptake by humans, environmental concentrations, known or suspected toxic effects, and the practical implication for human health risk assessments and public perception. Humans are already exposed to a range of natural and man-made nanoparticles in the air, and exposure via the food chain, water supply, and medical applications is likely. Toxicology studies on animals, and cells in vitro, raise the possibility of adverse effects on the immune system, oxidative stress related disorders, lung disease and inflammation. However, the doses needed to produce these effects are generally high and it remains to be seen if such exposure is possible via the environment or the work place. Data on exposure is also needed for risk calculations. Current legislation does not specifically address nanoparticles or nanomaterials, and there are concerns about nomenclature, defining nanomaterials as new substance under chemicals regulations such as REACH, and the appropriateness of current test methods.
14 October 2011 in Environmental Toxicology and Chemistry